Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a hypersensitivity reaction characterized by a generalized skin rash, fever, eosinophilia, lymphocytosis and visceral involvement (hepatitis, nephritis, pneumonitis, pericarditis and myocarditis) and, in some patients, reactivation of human herpes virus 6.
Biomarker and diagnostic research for drug rash with eosinophilia and systemic symptoms has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2, 1 EARLY_PHASE1. Research is primarily sponsored by academic and government institutions.
224 publications have been identified in PubMed for drug rash with eosinophilia and systemic symptoms. Kisho has analyzed 134 by research type. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 66 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:47 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
49%
Research summaries | 33 | 25% |
Disease patterns and progression | 12 | 9% |
Other research | 9 | 7% |
Laboratory research | 8 | 6% |
Testing and diagnosis research | 4 | 3% |
Clinical study results | 2 | 1% |
Ali SB (2026). [PMID: 41770659](https://pubmed.ncbi.nlm.nih.gov/41770659/). *Int Arch Allergy Immunol*. [Review / Meta-Analysis]
Elmehallawy GS (2026). [PMID: 41909301](https://pubmed.ncbi.nlm.nih.gov/41909301/). *Cureus*. [Review / Meta-Analysis]
Resende LO (2026). [PMID: 41604969](https://pubmed.ncbi.nlm.nih.gov/41604969/). *An Bras Dermatol*. [Epidemiology / Natural History]
Kumaran MS (2026). [PMID: 41729574](https://pubmed.ncbi.nlm.nih.gov/41729574/). *Indian Dermatol Online J*. [Epidemiology / Natural History]
Esnault S (2026). [PMID: 41761717](https://pubmed.ncbi.nlm.nih.gov/41761717/). *J Leukoc Biol*. [Review / Meta-Analysis]
Tempel P (2026). [PMID: 41344167](https://pubmed.ncbi.nlm.nih.gov/41344167/). *Pediatr Neurol*. [Case Report / Case Series]
Roos JE (2026). [PMID: 41697334](https://pubmed.ncbi.nlm.nih.gov/41697334/). *Radiologie (Heidelb)*. [Review / Meta-Analysis]
Sato K (2026). [PMID: 41743360](https://pubmed.ncbi.nlm.nih.gov/41743360/). *Clin Case Rep*. [Case Report / Case Series]
Bolzon A (2026). [PMID: 41327959](https://pubmed.ncbi.nlm.nih.gov/41327959/). *Ital J Dermatol Venerol*. [Review / Meta-Analysis]
Broderick D (2026). [PMID: 41585544](https://pubmed.ncbi.nlm.nih.gov/41585544/). *IDCases*. [Case Report / Case Series]
AI-curated news mentioning drug rash with eosinophilia and systemic symptoms
Updated Jul 1, 2026
A case report highlights granulomatous interstitial nephritis with perivascular involvement in a patient with carbamazepine-induced DRESS syndrome. This finding contributes to the understanding of renal complications associated with drug reactions.
A multicenter retrospective cohort study investigates the management and predictors of ICU admission in patients with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). The findings may inform clinical practices and improve patient outcomes in this rare condition.
A recent study highlights the severe delayed drug hypersensitivity reaction associated with allopurinol, known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This research underscores the need for increased awareness and monitoring of patients on allopurinol.